Disclosed is a process for performing a reductive amination of a first functional group in an organic feed substrate, which feed substrate comprises at least one further functional group containing a halogen atom, in the presence of hydrogen, a nitrogen-containing compound, and a catalyst, wherein the presence of the nitrogen-containing compound, expressed in a molar ratio relative to the first functional group in the organic feed substrate, at least during the reaction as long as the conversion of the organic feed substrate has not yet reached 80%, is maintained below a level of 1.3. Further disclosed is a composition of the invention comprising at least 98.0% wt of 2-chloro-benzyl-dimethylamine, at most 0.60% wt of the meso-o-Cl-BDMA dimer and at least 1 ppm wt of the (+/)-o-Cl-BDMA dimer and any use therefor.

The invention relates to a method for the preparation of di- and polyamines of the diphenylmethane series, care being taken during the shutdown of the production process that an excess of aniline and respect to formalin is ensured.

The invention relates to a method for the preparation of di- and polyamines of the diphenylmethane series, care being taken during the shutdown of the production process that an excess of aniline and respect to formalin is ensured.

The invention relates to a method for the preparation of di- and polyamines of the diphenylmethane series, care being taken during the shutdown of the production process that an excess of aniline and respect to formalin is ensured.

The present invention relates to unsaturated amine salts of HMG-CoA reductase inhibitors, to a method of producing said amine salts and to the use of said amine salts in the production of pharmaceutically acceptable salts of HMG-CoA reductase inhibitors.

The present invention relates to unsaturated amine salts of HMG-CoA reductase inhibitors, to a method of producing said amine salts and to the use of said amine salts in the production of pharmaceutically acceptable salts of HMG-CoA reductase inhibitors.

The invention relates to a method for the preparation of di- and polyamines of the diphenylmethane series (MDA) from aniline and formaldehyde, care being taken during the start up that a sufficient excess of aniline with respect to formaldehyde is ensured, said excess amounting to at least 105% of the desired molar ratio of aniline to formaldehyde for the target recipe of the MDA to be produced.

The invention relates to a method for the preparation of di- and polyamines of the diphenylmethane series (MDA) from aniline and formaldehyde, care being taken during the start up that a sufficient excess of aniline with respect to formaldehyde is ensured, said excess amounting to at least 105% of the desired molar ratio of aniline to formaldehyde for the target recipe of the MDA to be produced.

The invention relates to a method for the preparation of di- and polyamines of the diphenylmethane series (MDA) from aniline and formaldehyde, care being taken during the start up that a sufficient excess of aniline with respect to formaldehyde is ensured, said excess amounting to at least 105% of the desired molar ratio of aniline to formaldehyde for the target recipe of the MDA to be produced.

The invention relates to a method for producing aniline, comprising the steps of: a) providing o-aminobenzoate, wherein said o-aminobenzoate comprises anthranilate anion and a suitable cation, b) converting said anthranilate anion to aniline by thermal decarboxylation in the presence or absence of a catalyst, c) extracting the aniline produced in step b) in an organic solvent at least once, and d) purifying the aniline produced in steps b) and c) by distillation, wherein said distillation produces aniline and a water phase.